Having said that, employing oestrogen alone without having progesterone may lead to endometrial cancer. A hormone therapy medicine that combines estrogen and progestin, identified as blend hormone therapy, can lessen this chance. Ongoing Investigate: Clinical trials are underway to find out if cancer molecular profiling can be employed to forecast https://www.sgvascularctr.com/a-comprehensive-guide-to-uterine-fibroids-in-singapore/